Michael Way: Biography

Michael Way did his undergraduate in the Biophysics Department at King's College, University of London. During his PhD he studied the actin binding properties of gelsolinin the laboratory of Alan Weeds in the structural studies division of the Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.

In 1989 he received the Max Perutz Student Prize for his PhD work. He remained in Alan's lab as a postdoc for three years studying the actin binding properties of alpha-actinin, dystrophin and gelsolin before moving to Boston, for a second three year postdoc with Paul Matsudaira at the Whitehead Institute, Massachusetts Institute of Technology, USA.

In 1995, he moved back to Europe, starting his own group, studying vacciniavirus in the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany.

In 2001, Michael returned to London to head the Cell motility group in the London Research Institute, Cancer Research UK (now part of the Francis Crick Institute). His group uses a variety of quantitative imaging and biochemical approaches to study how vaccinia virus takes advantage of its host as a model system to understand signalling networks, cytoplasmic transport and cytoskeletal dynamics.

Michael has been an editor for the Journal of Cell Science since 2005 and was appointed its editor-in-chief in 2012. He is also on the editorial boards of Cellular Microbiology, Cell Host and Microbe, Developmental Cell, EMBO Journal, EMBO Reports and Small GTPases. He was elected an EMBO member in 2006. Michael is also an honorary Professor at UCL (University College London) as well as King's College London and, since October 2013, has also been a Professor of Virology at Imperial College London.

Michael Way

michael.way@crick.ac.uk
+44 (0)20 379 62068

  • Qualifications and History
  • 1988 PhD in Structural Studies, Cambridge University, UK
  • 1989 Postdoctoral Fellow, LMB, Cambridge, UK
  • 1992 Postdoctoral Fellow, Whitehead Institute, Massachusetts, USA
  • 1995 Group Leader, Cell Biology Programme, EMBL, Germany
  • 2001 Established lab at the Imperial Cancer Research Fund, UK (in 2002 the Imperial Cancer Research Fund became Cancer Research UK)
  • 2015 Group Leader, the Francis Crick Institute, London, UK